Vancomycin use in pediatric hematology-oncology patients

被引：20
|
作者：
Hopkins, HA
Sinkowitz-Cochran, RL
Rudin, BA
Keyserling, HL
Jarvis, WR
机构：
[1] Ctr Dis Control & Prevent, Hosp Infect Program, Natl Ctr Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Atlanta, GA 30333 USA
[2] Emory Univ, Egleston Childrens Hosp, Atlanta, GA 30322 USA
来源：
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2000年 / 21卷 / 01期
关键词：
D O I：
10.1086/501698
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
A cross-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. All patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations (Infect Central Hosp Epidemiol 2000; 21:48-50).
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [21] Invasive Fusariosis in Pediatric Hematology/Oncology and Stem Cell Transplant Patients: A Report from the Israeli Society of Pediatric Hematology-Oncology
    Benish, Marganit
    Elitzur, Sarah
    Arad-Cohen, Nira
    Barg, Assaf Arie
    Ben-Harosh, Miriam
    Bielorai, Bella
    Fischer, Salvador
    Gilad, Gil
    Levy, Itzhak
    Rosenfeld-Keidar, Hila
    Shachor-Meyouhas, Yael
    Soen-Grisaru, Galia
    Weinreb, Sigal
    Nirel, Ronit
    Elhasid, Ronit
    [J]. JOURNAL OF FUNGI, 2022, 8 (04)
  • [22] Seroprevalence of SARS-CoV-2 in pediatric hematology-oncology patients
    Phan, Vivian
    Richards, Tiana
    Kang, Keehyo
    Sheridan, Michael
    Levorson, Rebecca
    Defilippi, Christopher
    Yang, Elizabeth
    [J]. PEDIATRIC BLOOD & CANCER, 2024, 71 (10)
  • [23] Haploidentical allogeneic stem cell transplantation in pediatric hematology-oncology patients
    Paillard, C.
    Lutz, P.
    [J]. REVUE D ONCOLOGIE HEMATOLOGIE PEDIATRIQUE, 2015, 3 (04): : 206 - 214
  • [24] MYCOBACTERIUM PHOCAICUM BACTEREMIA: AN EMERGING INFECTION IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS
    Shachor-Meyouhas, Yael
    Geffen, Yuval
    Arad-Cohen, Nira
    Zaidman, Irina
    Ben-Barak, Ayelet
    Davidson, Sima
    Kassis, Imad
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (12) : 1299 - 1301
  • [25] Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients
    Vicenzi, Edoardo Bruno
    Calore, Elisabetta
    Decembrino, Nunzia
    Berger, Massimo
    Perruccio, Katia
    Carraro, Francesca
    Rossin, Sara
    Putti, Maria Caterina
    Molinaro, Mariadelfina
    Tridello, Gloria
    Cesaro, Simone
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (03) : 315 - 322
  • [26] Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients
    Suntharam, N
    Lankford, MG
    Trick, WE
    Peterson, LR
    Noskin, GA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (03) : 183 - 188
  • [27] Maximizing the Impact of a Pediatric Hematology-Oncology Twinning Program
    Slone, Jeremy S.
    Slone, Amanda K.
    Mehta, Parth S.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 369 - 369
  • [28] Outbreak of enteroviral infection in a pediatric hematology-oncology unit
    Moschovi, MA
    Theodoridou, M
    Papaevangelou, V
    Youroukos, S
    Nitsa, A
    Matsiota, P
    Tzortzatou-Stathopoulou, F
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) : 1269 - 1272
  • [29] Off label drugs and pediatric hematology-oncology practices
    Le Guyader, N.
    Pouliquen, A. -L.
    Benoit, G.
    Leverger, G.
    [J]. ARCHIVES DE PEDIATRIE, 2006, 13 (09): : 1267 - 1268
  • [30] Interprofessional Spiritual Care Education in Pediatric Hematology-Oncology
    Lion, A.
    Szilagyi, C.
    Varner Perez, S.
    Koch, S.
    Oyedele, O.
    Slaven, J.
    Montz, A.
    Haase, J.
    Puchalski, C.
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S105 - S106
12345